SNOA icon

Sonoma Pharmaceuticals
SNOA

Overview Fund Activity

22 hedge funds and large institutions have $870K invested in Sonoma Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
22
Holders Change
+4
Holders Change %
+22.22%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$254K
2
VF
2
Virtu Financial
New York
$67K
3
Citadel Advisors
3
Citadel Advisors
Florida
$42K
4
Goldman Sachs
4
Goldman Sachs
New York
$22K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$73K

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
CH
2
CVI Holdings
Delaware
$0
3
UBS Group
3
UBS Group
Switzerland
$13K
4
BA
4
Bard Associates
Illinois
$239K
5
Macquarie Group
5
Macquarie Group
Australia
$0
Name Market Value Shares Shares
Change 		Shares
Change %
1IA
26
1834 Investment Advisors
Wisconsin
$0 1 – –
Bank of America
27
Bank of America
North Carolina
$0 3 – –
Wells Fargo
28
Wells Fargo
California
– – – –
GI
29
Gradient Investments
Minnesota
$0 2 – –
Barclays
30
Barclays
United Kingdom
$0 1 +1 New
1
2